Global precision medicine software market
DUBLIN, April 16, 2024 (GLOBE NEWSWIRE) — “Precision Medical Software Market – Global and Regional Analysis: Focus on Product Types, Applications, End Users and Regions – Analysis and Forecasts, 2024 – 2033” report added.to ResearchAndMarkets.com Recruitment.
The global precision medicine software market was valued at $1,824.9 million in 2023 and is expected to reach $5,696.3 million by 2033, growing at a CAGR of 12.13% from 2024 to 2033. Masu.
Precision medicine software is a key element of the evolving landscape of healthcare, aiming to move away from a one-size-fits-all approach to a more customized and effective model of care. The integration of advanced technologies such as artificial intelligence and machine learning further enhances precision medicine software’s ability to analyze complex data sets and derive meaningful insights for personalized healthcare strategies.
The precision medicine software market has experienced significant growth in recent years due to the convergence of healthcare and cutting-edge technology. Precision medicine is characterized by a focus on individual patient variability in genetics, environment, and lifestyle, facilitating the development and implementation of specialized software solutions. These services span genomics analysis, clinical decision support, data integration, patient engagement, and research support. Advances in genomic technology and increasing understanding of genetic contributions to disease have propelled the market forward.
Impact on industry
The industrial influence on the precision medicine software market is significant, with various sectors contributing to the growth and advancement of this specialty. Industries such as biotechnology, pharmaceuticals, and information technology have played a pivotal role in driving innovation and shaping the precision medicine software landscape. The biotechnology industry has contributed to the development of advanced genomic technologies, which allow individual genetic data to be analyzed and interpreted on a larger scale.
On-premise sector dominates precision medicine software market (by delivery mode)
Based on delivery mode, the global precision medical software market will be led by the on-premises sector, which will hold a share of 65.38% in 2023, mainly due to several key factors such as rising concerns over data security in the healthcare sector accounted for. By choosing an on-premises solution, organizations gain complete control over sensitive patient information and ensure compliance with strict regulatory standards such as HIPAA and GDPR. Additionally, the ability to customize software configurations and seamlessly integrate with existing legacy systems makes on-premises an attractive option for healthcare organizations with specific workflow requirements.
Oncology segment dominates precision medicine software market (by application)
Based on application, the global precision medicine software market was led by the oncology sector, which accounted for a share of 47.60% in 2023. This is mainly due to the fact that oncology is one of the complex and complex fields of medical application. The diverse nature of cancer and the need for patient-tailored treatment approaches. Precision medicine software offers advanced analytical and predictive modeling capabilities that are particularly suited to oncology, allowing healthcare providers to analyze genomic data, identify molecular biomarkers, and develop treatment strategies based on individual patient characteristics. Allow for personalization.
Healthcare Provider Segment Dominates the Precision Medicine Software Market (by End User)
Based on end users, the global precision medicine software market was led by healthcare providers segment, accounting for 58.20% share in 2023. This is primarily because healthcare providers play a central role in the implementation and use of precision medicine software. To provide personalized care to patients. Precision medicine software provides healthcare providers with advanced tools and analytical capabilities to analyze patient data, including genetic information, and adjust treatment plans accordingly. Additionally, healthcare providers are increasingly recognizing the potential of precision medicine to improve clinical outcomes, increase patient satisfaction, and optimize resource utilization.
What value does this report bring to your organization?
Product/Innovation Strategy: The global precision medicine software market is segmented on the basis of various categories such as product type, application, end user, and region.
Growth/Marketing Strategy: The maximum number of major developments, together with product launches, upgrades, and synergies accounted for nearly 88.24% of the total development of the Precision Medicine Software market from January 2021 to December 2023.
Competitive strategy: The global precision medicine software market is a highly fragmented market, with many small private companies constantly entering the market. The key players in the precision medicine software market analyzed and profiled in this study include established players offering different types of products.
Key attributes:
|
report attributes |
detail |
|
number of pages |
104 |
|
Forecast period |
2024-2033 |
|
Estimated market value in 2024 (USD) |
$2.03 billion |
|
Projected market value to 2033 (USD) |
$5.69 billion |
|
compound annual growth rate |
12.1% |
|
Target area |
global |
Market trend
Trends: Current and future impact assessments
market drivers
market constraints
market opportunity
Supply chain overview
Overview of key market players and competition
-
2b accurate
-
F. Hoffman La Roche Co., Ltd.
-
Verasight Co., Ltd.
-
Roper Technologies Co., Ltd.
-
Fabric Genomics Co., Ltd.
-
flatiron health
-
Genedata AG
-
Koninklijke Philips NV
-
Lifeomic Holdings LLC
-
Nantes Health Co., Ltd.
-
Pyrian Dx
-
Qiagen NV
-
Sophia Genetics SA
-
Shapse Co., Ltd.
-
Tempus Lab Co., Ltd.
For more information about this report, please visit https://www.researchandmarkets.com/r/i5l1hl.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
